Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Furazolidone-containing triple and quadruple therapy for Helicobacter pylori in China
ChiCTR-OPC-16009523Phase 4Completed
- Sponsor
- First Affiliated Hospital of Nanchang University
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of furazolidone in Helicobacter pylori infection (4 arms), sponsored by First Affiliated Hospital of Nanchang University. Primary endpoint: H. pylori eradication rate. Started Feb 2011; status: completed.
02
Drugs
furazolidone
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR-OPC-16009523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-16009523.